|
|
|
|
|
Analgesic, Anti-inflammatory & Anti-Pyretic |
|
SR. NO. |
PRODUCT
NAME |
STRENGTH |
|
1 |
Aceclofenac
& Paracetamol Tablets |
100+325
mg/100+500 mg |
|
2 |
Aceclofenac
& Paracetamol Oral Suspension |
50+125
mg |
|
3 |
Aceclofenac
& Serratiopeptidase Tablets |
100+15
mg |
|
4 |
Aceclofenac,
Paracetamol & Chlorzoxazone Tablets |
100+325+500
mg |
|
5 |
Aceclofenac,
Paracetamol & Serratiopeptidase Tablets |
100+325+15/100+500+15
mg |
|
6 |
Celecoxib
Capsules |
100/200
mg |
|
7 |
Dexibuprofen
& Paracetamol Tablets |
300+500
mg |
|
8 |
Diclofenac
Prolonged-Release Capsules |
100mg |
|
9 |
Diclofenac
Prolonged-Release Tablets |
100mg |
|
10 |
Diclofenac
Sodium & Paracetamol Tablets |
50+325mg/50+500mg |
|
11 |
Diclofenac
Sodium, Paracetamol & Chlorzoxazone Tablets |
50+325+250mg/50+500+250mg |
|
12 |
Diclofenac
Sodium, Paracetamol, Chlorpheniramine Maleate & Magnesium Trisilicate
Tablets |
50+325+4+100mg/50+500+4+100mg |
|
13 |
Diclofenac
Tablets (Gastro-Resistant) |
50mg |
|
14 |
Dipyrone
Tablets |
500mg |
|
15 |
Etoricoxib
Tablets |
60/90/120
mg |
|
16 |
Gabapentin
Capsules |
100/300/400
mg |
|
17 |
Ibuprofen
& Paracetamol Tablets |
200+500mg/400+325mg/400+500mg |
|
18 |
Ibuprofen
Tablets |
200/400mg |
|
19 |
Ibuprofen,
Paracetamol & Caffeine Capsules |
200+325+40mg/400+325+40mg |
|
20 |
Indomethacin
Capsules |
25mg |
|
21 |
Indomethacin
SR Capsules |
75mg |
|
22 |
Ketoprofen
Tablets |
100/200
mg |
|
23 |
Lornoxicam
Tablets |
4/8/16
mg |
|
24 |
Mefenamic
Acid & Dicyclomine Tablets |
250+
10 mg |
|
25 |
Mefenamic
Acid Tablets |
100/250/500
mg |
|
26 |
Meloxicam
Tablets |
7.5/15
mg |
|
27 |
Naproxen
Tablets |
500mg |
|
28 |
Orphenadrine
& Paracetamol Tablets |
35+450
mg |
|
29 |
Orphenadrine
Tablets |
50mg |
|
30 |
Paracetamol
& Chlorzoxazone Tablets |
250+500
mg |
|
31 |
Paracetamol
Tablets |
500mg |
|
32 |
Piroxicam
Capsules |
20mg |
|
33 |
Pregabalin
Capsules |
25/50/75/150/300
mg |
|
34 |
Serratiopeptidase
Tablets+A20 |
10
mg |
|
35 |
Tramadol
Capsules |
50mg |
|
36 |
Paracetamol
& Mefanamic acid Suspension |
|
|
|
|
|
|
|
|